SYDNEE TORRENCE WEBER: Open Payments
NPI 1386124881 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,562 in 65 payments from 12 companies in 2025. Trend: 2023 $183 · 2024 $550 · 2025 $1,562
Food & beverage: $1,462Education: $100
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 24 | $575 |
| Teva Pharmaceuticals USA, Inc. | 9 | $249 |
| Vanda Pharmaceuticals Inc. | 10 | $230 |
| Lundbeck LLC | 6 | $133 |
| Neurocrine BioSciences, Inc. | 3 | $69 |
| Alkermes, Inc. | 3 | $69 |
| ABBVIE INC. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Bausch Health US, LLC | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $34 |
Products named: REXULTI, FANAPT, UZEDY, INGREZZA, ARISTADA, VRAYLAR, TRINTELLIX, ABILIFY ASIMTUFII.
Industry payments across OR — which companies pay providers there.
